Clinical trial
HF2 Therapy in the Treatment of Active Ulcerative Colitis:
NCT03720002 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HF2 Therapy in the Treatment of Active Ulcerative Colitis:
- Lead sponsor
- Sheba Medical Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 29, 2019
- Completion date
- February 1, 2023
- Enrollment
- 52 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis